维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="Oremek"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Pre - analytical problems in the measurement of tumor type pyruvate kinase (tumor M2 - PK) 显示文摘	Oremek GM Gerstmeier F Sauer - Eppel H	2003	Anticancer Res2003，23，2：	1
2	Value of tumor and inflammatory markers in lung cancer 显示文摘	Oremek GM Sauer - Eppel H Bruzdziak TH	2007	Anticancer Res2007，27，4：	1
3	The significance of TU M2-PK tumor marker for lung cancer diagnostics 显示文摘	Oremek G Kukshaite R Sapoutzis N	2007	Klin Med(Mosk)2007，85，7：	1
4	CY- FRA21-1-einneuer Tumormarker aus der Zytokeratinreihe in der Differentialdialdiagnostik von Lungenerkrankungen 显示文摘	Oremek GM Seiffert US Siekmeier R Kirsten R	1995	Med Klin1995，90，：	1
5	Prospective multicenter evaluation of fecal tumor pyravate kinase type M2 ( M2 - PK) as a screening biomarker for colorectal neoplasia显示文摘	Shastri YM Naumann M Oremek GM	2006	lnt J Cancer2006，119，11：	1
6	Prospective multi- center evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for eolore显示文摘	Shastri YM Naumman M Oremek GM	2006	Int J Cancer2006，119，11：	1
7	Progastrin releasing peptide(Pro GRP),tumor marker for small cell lung cancer显示文摘	Oremek GM Sapoutzis N	2003	Anticancer Res2003，23，2：	1
8	Value of tumour and inilammatory markers in lung cancer显示文摘	Oremek GM Sauer-Eppel H Bruzdziak TH	2007	Antieancer Res2007，27，4：	1
9	Value of tumour and inflammatory markers in lung cancer显示文摘	Oremek G M Sauer-eppel H Bnlzdziak T H	2007	Anticancer Res2007，27，4：	1
10	Value of tumor M2 (TU M2 -PK) in patients with renal carcinoma显示文摘	Oremek GM Sapoutzis N Kramer W	2000	Anticancer Res2000，20，6：	1
11	Preanalytical problems in the measurement of tumor type pyruvate kinase(tumor M2-PK) 显示文摘	Oremek GM Gerstmeier F Sauer-eppel H	2003	Anticancer Res2003，23，2：	1
12	Value of TRACP 5b as a diagnostic marker for detection of bone metastases in patients with breast cancer显示文摘	Hung MJ Oremek GM	2011	Eur J Gynaecol Oncol2011，32，6：	1
13	Value of tumour and inflammatory markers in lung cancer显示文摘	Oremek GM Sauer-Eppel H Bruzdziak TH	2007	Anticancer Res2007，27，4：	1
14	Complexed PSA in routine diagnosis显示文摘	Oremek G M Sapoutzis N Eden F	2003	Anticancer-Res2003，23，2：	1
15	Complexed PSA in routine diagnosis显示文摘	Oremek GM Sapontzis N Eden F	2003	Anticancer Res2003，23，：	1
16	Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy显示文摘	Oremek GM Rutner F Sapoutzis N	2003	Anticancer Res2003，23，2：	1
17	Enhancement of photodynamic therapy by use of aminolvulinic acid/glycolic acid drug mixture显示文摘	Ziolkowski P Osiecka B J Oremek G		0，，02：	1
18	Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy显示文摘	Oremek G M Rutner F Sapoutzis N	2002	Anticancer research2002，23，2：	1
19	Lab Med显示文摘	Oremek G M Seiffert U B Zirker M	1993	16(11):3551993，16，11：	1
20	Value of tumour and inflammatory, markers in lung cancer显示文摘	Oremek G M Sauer-Eppel H Bruzdziak T H	2007	Anticancer Res2007，27，4：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示